METHOD FOR TRANSPLANTATION OF ANIMAL CELL, TISSUE OR ORGAN FOR A RECIPIENT AND PREPARATION FOR ITS IMPLEMENTATION Russian patent published in 2003 - IPC

Abstract RU 2195956 C2

FIELD: medicine, immunology. SUBSTANCE: the method deals with transplantation in combination with one or several homologous complement restriction factors (HCRF), active in a recipient form, to prevent complete complement activation. HCRF represents or is of factor 1 activity (inactivator C3b or KAF), factor H, C4- binding protein, DAF (CD55), membranous cofactor protein (MCP, CD46, gp 45-70 or gp 66/56), CR1 (receptor C3b/C4b or CD35), CR2 (CD21, receptor C3.dg, receptor 3d/EBV and p140). Donor tissue could be transgenic and express HCRF-coding HK for a recipient during transplantation. To fulfill the method one should use a preparation being a homologous complement restriction factor (HCRF) active in a recipient form. Both the method and preparation enable to prevent the detachment of a transplant. EFFECT: higher efficiency. 17 cl, 22 dwg, 14 ex

Similar patents RU2195956C2

Title Year Author Number
METHOD FOR OBTAINING TRANSGENIC ANIMAL 1990
  • Uajt Dehvid Dzhejms Grekhem
  • Vill'Jams Alan Frederik
RU2252533C2
PROLONGATION OF ALLOGRAFT SURVIVAL BY COMPLEMENT ACTIVITY INHIBITION 2007
  • Roter Rassell P.
  • Van Khao
  • Chzhun Chzhen'
RU2445975C2
POPULATION OF PIGS WITH LOW LEVELS OF PORCINE ENDOGENOUS RETROVIRUS AND ITS APPLICATION 2006
  • Ehlliott Robert Bartlett
  • Garkavenko Ol'Ga
  • Fergjuson Aleksander Berns
RU2412592C2
HUMAN MODIFIED PROTEIN C3, DNA FRAGMENT, CONJUGATE, PHARMACEUTICAL COMPOSITION, METHOD OF DECREASE OF PROTEIN AMOUNT CONTENT 1995
  • Garrison Richard Aleksandr
  • Fehrriz Timoti Charl'Z
RU2194713C2
AGENTS SUPPRESSING REJECTION OF TRANSPLANT 2002
  • Suzuki Sejiti
  • Isobe Mitsuaki
RU2263512C2
PROTEIN ELICITING ABILITY FOR FORMATION OF C3-CONVERTASE, DNA, VECTOR, CONJUGATE AND THEIR USING 1997
  • Farris Timoti Charlz
  • Kharrison Richard Aleksandr
RU2238322C2
METHODS AND COMPOSITIONS FOR PROLONGING SURVIVAL AFTER ORTHOPIC AND HETEROTOPIC TRANSPLANTATION OF XENOGENIC HEART, KIDNEY, LUNG OR LIVER 2019
  • Reichart, Bruno
  • Abicht, Jan-Michael
  • Mayr, Tanja
  • Laengin, Matthias
  • Brenner, Paolo
  • Wolf, Eckhard
  • Klymiuk, Nikolai
RU2795429C2
APPLICATION OF CARBON OXIDE FOR IMPROVEMENT OF TISSUE AND ORGAN TRANSPLANTATION ISSUE AND APOPTOSIS SUPPRESSION 2002
  • Bakh Fritts Kh.
  • Tobiash Ehdda M.
  • Soarez Migel' K.
  • Otterbajn Leo Eh.
  • Gous Dzhinn
RU2376997C2
METHODS FOR INDUCING T-CELLULAR TOLERANCE FOR TISSUE OR ORGAN TRANSPLA - NT 1995
  • Noelle Randol'F Dzh.
  • D'Juri Fiona Kh.
  • Parker Dehvid S.
  • Ehppel Majkl S.
  • Filips Nehnsi E.
  • Mordes Dzhon P.
  • Grenajr Dehjl L.
  • Rossini Aldo A.
RU2169009C2
DIAGNOSTICUM FOR IDENTIFYING DONOR-SPECIFIC MAJOR HISTOCOMPATIBILITY COMPLEX ANTIBODIES AND METHOD FOR PREPARING IT 2012
  • Khubutija Mogeli Shalvovich
  • Borovkova Natal'Ja Valer'Evna
  • Doronina Natal'Ja Viktorovna
  • Guljaev Vladimir Alekseevich
  • Minina Marina Gennad'Evna
  • Zherzdev Sergej Vasil'Evich
  • Ponomarev Ivan Nikolaevich
  • Khvatov Valerij Borisovich
RU2491552C1

RU 2 195 956 C2

Authors

Uajt Dehvid Dzhejms Grekhem

Vill'Jams Alan Frederik

Dates

2003-01-10Published

1990-10-12Filed